PreVu® Non-Invasive Skin Cholesterol Point of Care Test has been cleared for sale by Health Canada
News & Media
Scientists at CCARM were looking to attract attention to their display on the potential health benefits of pulse crops
Expands Enrollment with Addition of Trial Site in India
The Manitoba Knights is a group that was formed in the fall, loosely connected to Biomedical Commercialization Canada
Manitoba could be a petri dish for health-care innovations that could save the government $500 million a year.
On Wednesday afternoon, five Winnipeg technology companies showed off the scope of innovation and enterprise that exists in Winnipeg. The fact most of them need additional capital and other strategic assistance to survive does not detract from the exce
A class II medical device license application was filed for the Non-Invasive Skin Cholesterol Point of Care test
$400,000 in grants provide financial incentive to use biomass.
Manitoba Premier Greg Selinger announced today new Minister of agriculture, food and rural initiatives.
Thanks to combined investments of $1.2 million from the Governments of Canada and of Manitoba business leaders from around the world will have an opportunity to participate in Centralia 2012.
Congratulations to Conviron for winning Manitoba's Exporter of the Year and Intelligent Hospital Systems for winning the CME's Emerging award.
Centrallia 2012 is what we're calling speed-dating for business. We want to hook you up and help you build new relationships, so your business prospers.
DiaMedica announced the successful humanization of its monoclonal antibody DM-204 for Type 2 diabetes and diabetic related complications of hypertension and cholesterol.
Intelligent Hospital Systems is building its order book for its million-dollar robotic pharmaceutical dispensers
Intelligent Hospital Systems has announced the release of a new enhanced version of Robotic Intravenous Automation.
DiaMedica's DM-199 for Type 1 Diabetes significantly delays autoimmune attack and demonstrates a dramatic increase in C-Peptide levels
DiaMedica reported that chronic administration of DM-199 significantly delayed the autoimmune attack, preserved beta cell mass and demonstrated a 12-fold increase in circulating C-peptide levels in an in vivo study.
Medicure reported a first-quarter profit of $23.5 million, reversing a year-ago net loss of $1.6 million as it booked a $23.9-million non-cash gain on a debt settlement.
DiaMedica’s DM-204 for Type 2 Diabetes Significantly Lowers Blood Glucose, Blood Pressure and Cholesterol Levels
DiaMedica presented new compelling Type 2 diabetes data from studies of DM-204 at the Windhover Therapeutic Area Partnership Conference in Boston, MA, USA.
The $50 million Agricultural Innovation Program, which will boost the development and commercialization of innovative new products, technologies and processes in the agricultural sector was announced by Agriculture Minister Gerry Ritz.
GSK announced the launch of a new national fund that will significantly advance the commercialization of scientific innovation in Canada by investing in early stage breakthrough research.
Wendy Smith, a local prosthetist whose quest to build a better breast for women who have undergone a full or partial mastectomy just got a $97,000 financial boost from the federal government.